当前位置:首页 - 行情中心 - 天域生物(603717) - 财务分析 - 现金流量表

天域生物

(603717)

  

流通市值:20.46亿  总市值:20.46亿
流通股本:2.90亿   总股本:2.90亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金199,143,976.43964,415,680.08655,625,079.61440,759,800.45
  收到的税费返还-152,238.3572,168.9572,168.95
  收到其他与经营活动有关的现金18,705,539.17136,103,258.57109,519,390.286,194,348.87
  经营活动现金流入小计217,849,515.61,100,671,177765,216,638.76527,026,318.27
  购买商品、接受劳务支付的现金205,725,849.48629,568,533.74473,268,894.67332,540,324.98
  支付给职工以及为职工支付的现金19,390,709.2583,971,946.2959,617,446.4242,021,820.7
  支付的各项税费1,799,582.516,472,654.156,690,899.254,575,340.69
  支付其他与经营活动有关的现金32,302,878.61112,360,340.2178,427,861.5958,063,101.35
  经营活动现金流出小计259,219,019.84842,373,474.39618,005,101.93437,200,587.72
  经营活动产生的现金流量净额-41,369,504.24258,297,702.61147,211,536.8389,825,730.55
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额35,000200,782.5423,825.54200
  收到的其他与投资活动有关的现金32,461,407.3312,535,404.981,535,404.98535,404.98
  投资活动现金流入小计32,496,407.3312,736,187.521,559,230.52535,604.98
  购建固定资产、无形资产和其他长期资产支付的现金2,340,815.4353,479,070.8434,467,958.725,928,304.31
  投资支付的现金7,415,0002,045,000--
  取得子公司及其他营业单位支付的现金-60,509,397.5430,394,397.5420,740,000
  支付其他与投资活动有关的现金11,550,00019,660,650.094,160,650.09159,649.09
  投资活动现金流出小计21,305,815.43135,694,118.4769,023,006.3346,827,953.4
  投资活动产生的现金流量净额11,190,591.9-122,957,930.95-67,463,775.81-46,292,348.42
三、筹资活动产生的现金流量:
  吸收投资收到的现金890,000800,000800,000-
  其中:子公司吸收少数股东投资收到的现金890,000800,000800,000-
  取得借款收到的现金34,770,969.04115,926,150.4248,618,543.4244,166,931.42
  收到其他与筹资活动有关的现金135,000,000222,145,300156,300,00047,100,000
  筹资活动现金流入小计170,660,969.04338,871,450.42205,718,543.4291,266,931.42
  偿还债务支付的现金1,978,571.41172,619,284.1466,704,344.8937,879,867.71
  分配股利、利润或偿付利息支付的现金8,298,951.7350,055,246.8240,022,030.0318,491,837.38
  支付其他与筹资活动有关的现金146,262,613.88260,919,570.08200,398,190.1886,619,041.59
  筹资活动现金流出小计156,540,137.02483,594,101.04307,124,565.1142,990,746.68
  筹资活动产生的现金流量净额14,120,832.02-144,722,650.62-101,406,021.68-51,723,815.26
四、汇率变动对现金及现金等价物的影响4,242.1657,484.872,474.6683,888.44
五、现金及现金等价物净增加额-16,053,838.16-9,325,394.16-21,585,786-8,106,544.69
  加:期初现金及现金等价物余额90,941,798.16100,267,192.32100,267,192.32100,267,192.32
  期末现金及现金等价物余额74,887,96090,941,798.1678,681,406.3292,160,647.63
补充资料:
  净利润--102,015,606.15-31,869,621.31
  资产减值准备-22,928,085.66--7,161,672.76
  固定资产和投资性房地产折旧-40,598,027.29-19,265,407.3
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-40,598,027.29-19,265,407.3
  无形资产摊销-1,007,678.95-507,644.19
  长期待摊费用摊销-1,719,604.17-990,417.49
  处置固定资产、无形资产和其他长期资产的损失--25,973,538.27--25,911,620.61
  固定资产报废损失-1,849,051.35-729,487.95
  公允价值变动损失--8,633,602.76--
  财务费用-53,680,430.16-32,651,064.3
  投资损失-4,114,472.65-1,060,660.84
  递延所得税-3,122,465.06--130,174.51
  其中:递延所得税资产减少-3,354,407.6--9,006.76
    递延所得税负债增加--231,942.54--121,167.75
  存货的减少-211,886,357.29-185,576,376.81
  经营性应收项目的减少-60,730,663.36--48,300,802.15
  经营性应付项目的增加--26,883,795.32--113,750,762.9
  现金的期末余额-90,941,798.16-92,160,647.63
  减:现金的期初余额-100,267,192.32-100,267,192.32
  现金及现金等价物的净增加额--9,325,394.16--8,106,544.69
公告日期2026-04-302026-04-302025-10-302025-08-30
审计意见(境内)标准无保留意见
TOP↑